-
公开(公告)号:US07964580B2
公开(公告)日:2011-06-21
申请号:US12053015
申请日:2008-03-21
申请人: Michael Joseph Sofia , Jinfa Du , Peiyuan Wang
发明人: Michael Joseph Sofia , Jinfa Du , Peiyuan Wang
CPC分类号: A61K31/7072 , A61K31/706 , A61K31/7064 , A61K31/7068 , A61K31/7076 , A61K45/06 , C07D417/14 , C07H17/02 , C07H19/04 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/20 , Y02A50/463
摘要: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
摘要翻译: 本文公开了用于治疗哺乳动物病毒感染的核苷衍生物的氨基磷酸酯前药,哺乳动物是由以下结构表示的化合物,其立体异构体,盐(酸或碱加成盐),水合物,溶剂合物或结晶形式:也 披露了使用式I化合物制备各种方法的处理方法,用途和方法。
-
公开(公告)号:US20100286083A1
公开(公告)日:2010-11-11
申请号:US12645710
申请日:2009-12-23
IPC分类号: A61K31/7076 , C07H19/207 , C07H19/10 , A61K31/7072 , A61P31/16 , A61P31/12
摘要: A purified compound having activity against hepatitis C virus is disclosed.
摘要翻译: 公开了具有抗丙型肝炎病毒活性的纯化合物。
-
公开(公告)号:US08551973B2
公开(公告)日:2013-10-08
申请号:US12645710
申请日:2009-12-23
摘要: A purified compound having activity against hepatitis C virus is disclosed.
摘要翻译: 公开了具有抗丙型肝炎病毒活性的纯化合物。
-
公开(公告)号:US08334270B2
公开(公告)日:2012-12-18
申请号:US13099671
申请日:2011-05-03
CPC分类号: A61K31/7072 , A61K31/706 , A61K31/7064 , A61K31/7068 , A61K31/7076 , A61K45/06 , C07D417/14 , C07H17/02 , C07H19/04 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/20 , Y02A50/463
摘要: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
摘要翻译: 本文公开了用于治疗哺乳动物病毒感染的核苷衍生物的氨基磷酸酯前药,哺乳动物是由以下结构表示的化合物,其立体异构体,盐(酸或碱加成盐),水合物,溶剂合物或结晶形式:也 披露了使用式I化合物制备各种方法的处理方法,用途和方法。
-
-
-